DexCom Cash on Hand 2012-2026 | DXCM
DexCom cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- DexCom cash on hand for the quarter ending June 30, 2026 was $1.947B, a 33.53% decline year-over-year.
- DexCom cash on hand for 2025 was $1.999B, a 22.51% decline from 2024.
- DexCom cash on hand for 2024 was $2.579B, a 5.31% decline from 2023.
- DexCom cash on hand for 2023 was $2.724B, a 10.91% increase from 2022.
|
DexCom Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $1,999 |
| 2024 | $2,579 |
| 2023 | $2,724 |
| 2022 | $2,456 |
| 2021 | $2,731 |
| 2020 | $2,708 |
| 2019 | $1,533 |
| 2018 | $1,386 |
| 2017 | $549 |
| 2016 | $124 |
| 2015 | $115 |
| 2014 | $84 |
| 2013 | $55 |
| 2012 | $49 |
| 2011 | $82 |
|
DexCom Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-06-30 | $1,947 |
| 2026-03-31 | $2,415 |
| 2025-12-31 | $1,999 |
| 2025-09-30 | $3,322 |
| 2025-06-30 | $2,929 |
| 2025-03-31 | $2,701 |
| 2024-12-31 | $2,579 |
| 2024-09-30 | $2,492 |
| 2024-06-30 | $3,121 |
| 2024-03-31 | $2,897 |
| 2023-12-31 | $2,724 |
| 2023-09-30 | $3,240 |
| 2023-06-30 | $3,636 |
| 2023-03-31 | $2,567 |
| 2022-12-31 | $2,456 |
| 2022-09-30 | $2,372 |
| 2022-06-30 | $2,755 |
| 2022-03-31 | $2,688 |
| 2021-12-31 | $2,731 |
| 2021-09-30 | $2,698 |
| 2021-06-30 | $2,585 |
| 2021-03-31 | $2,633 |
| 2020-12-31 | $2,708 |
| 2020-09-30 | $2,604 |
| 2020-06-30 | $2,509 |
| 2020-03-31 | $1,511 |
| 2019-12-31 | $1,533 |
| 2019-09-30 | $1,430 |
| 2019-06-30 | $1,378 |
| 2019-03-31 | $1,358 |
| 2018-12-31 | $1,386 |
| 2018-09-30 | $669 |
| 2018-06-30 | $606 |
| 2018-03-31 | $534 |
| 2017-12-31 | $549 |
| 2017-09-30 | $526 |
| 2017-06-30 | $497 |
| 2017-03-31 | $181 |
| 2016-12-31 | $124 |
| 2016-09-30 | $127 |
| 2016-06-30 | $116 |
| 2016-03-31 | $107 |
| 2015-12-31 | $115 |
| 2015-09-30 | $113 |
| 2015-06-30 | $98 |
| 2015-03-31 | $84 |
| 2014-12-31 | $84 |
| 2014-09-30 | $75 |
| 2014-06-30 | $61 |
| 2014-03-31 | $57 |
| 2013-12-31 | $55 |
| 2013-09-30 | $48 |
| 2013-06-30 | $46 |
| 2013-03-31 | $45 |
| 2012-12-31 | $49 |
| 2012-09-30 | $53 |
| 2012-06-30 | $61 |
| 2012-03-31 | $70 |
| 2011-12-31 | $82 |
| 2011-09-30 | $97 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $31.955B | $4.662B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |